The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,737.50
Bid: 1,737.00
Ask: 1,737.50
Change: -2.50 (-0.14%)
Spread: 0.50 (0.029%)
Open: 1,730.00
High: 1,744.50
Low: 1,729.00
Prev. Close: 1,740.00
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

WINNERS & LOSERS: Evraz Up On USD375 Million Return To Shareholders

Wed, 01st Apr 2015 10:42

LONDON (Alliance News) - The following stocks are amongst the biggest risers and fallers within the main London indices midday Wednesday.
-------
FTSE 100 WINNERS
-------
Barclays, up 3.6% at 251.25 pence, Lloyds Banking Group, up 2.0% at 80.33p, and Royal Bank of Scotland Group up 2.1% at 347.2p. The banking stocks are reversing all the losses they made on Tuesday. Morgan Stanley lifted its price target for Barclays to 333.2 pence from 315.5p, reiterating its Overweight rating, while it also raised its RBS price target to 391.6p from 375p, keeping its Equal-Weight rating. Meanwhile, Jefferies upgraded Lloyds to Hold from Underperform, saying the group's premium valuation is now supported by a progressively rising dividend.

Royal Dutch Shell 'B', up 2.2%. Reuters reports the US government upheld a 2008 lease sale in the Chukchi Sea off Alaska, meaning Shell has moved closer to returning to exploration work in the region since it lost control of the Kulluk oil rig in 2012. The Interior's Bureau of Ocean Energy Management will now consider Shell's exploration plan and will perform an environmental assessment of it, which would take at least 30 days. But Shell, in anticipation of returning to the region, has already moved rigs to Alaska, Reuters said.

Glaxosmithkline, up 2.3% at 2,144.5p. Barclays raised its price target for the pharmaceutical company to 1,840p from 1,690p, keeping its Overweight recommendation.
-------
FTSE 100 LOSERS
-------
Kingfisher, down 2.0%. The shares of the DIY retailer are down after rising 4.4% to a nine-month high on Tuesday as it reported a drop in sales and profit for its last financial year which it blamed on a slower French market and the strength of sterling, but said the new CEO plans to organise the company "very differently" to create a unified business that will share IT systems and buying and stock inventory infrastructure. Meanwhile, Nomura has cut its price target for Kingfisher to 305p from 315p, retaining its Neutral recommendation.
-------
FTSE 250 WINNERS
-------
Evraz, up 6.5%. The steel miner said it will return USD375 million to its shareholders even though its pretax loss widened in 2014 on the back of a USD1.0 billion foreign exchange loss caused by the devaluation of the rouble, saying it has "improved business prospects" in 2015. Evraz reported a pretax loss of USD1.08 billion in 2014, compared with a USD637 million loss in 2013, on the back of the substantial foreign exchange loss and an impairment charge.

Firstgroup, up 4.4%. The transport company said its trading in the fourth quarter and whole of the financial year that ended on Tuesday was in line with its expectations, with good performances in its UK bus and rail operations. FirstGroup said its UK bus business is delivering volume growth and achieving a positive yield, and it has made progress on cost-cutting efforts within the division. Separately, Panmure Gordon upgraded the transport company to Buy from Hold, cutting its price target to 120p from 140p.
-------
AIM ALL-SHARE WINNERS
-------
CEB Resources, up 70%. The natural resources focused investment company said it has sold its remaining stake in Australian Securities Exchange-listed Balamara Resources. In October, CEB Resources sold a third of its shares in Balamara for AUD350,340. Wednesday it sold its remaining stake, selling 9.8 million shares for AUD178,108, representing a much lower price compared with the sale in October last year.

Daily Internet, up 12%. The hosting and cloud infrastructure company said its expects its results for the year to the end of March be significantly improved on the prior year. It expects revenue to be ahead of market expectations and expects earnings before interest, taxation, depreciation and amortisation to be "materially ahead" of market forecasts. The company also said its Netplan Internet Solutions Ltd business has a series of contracts worth a total of GBP565,000 with a global insurance company.
-------
AIM ALL-SHARE LOSERS
-------
Amerisur Resources, off 27%. The company said its reserves and resources for its exploration and production assets in Colombia and Paraguay fell following an independent reserves report undertaken by Petrotech Engineering. The report concluded that the company's proven gross field reserves was 16.2 million barrels of oil, down from 19.8 million barrels in 2013, whilst proven plus probable gross field reserves fell to 24.6 million barrels from 32.8 million barrels.

The Real Good Food, down 14%. The company said the fall in European Union sugar prices has meant trading in its Napier Brown and Garrett Ingredients businesses has been very difficult. Napier Brown returned to profit in the second half, it said, but remains behind expectations for the year. The company said the group outside of Napier and Garrett performed ahead of expectations, with its Renshaw and Haydens businesses both performing well.

By Daniel Ruiz; danielruiz@alliancenews.com

Copyright 2015 Alliance News Limited. All Rights Reserved.

More News
9 Oct 2023 07:42

LONDON BRIEFING: Metro Bank secures deal to shore up finances

(Alliance News) - Stocks in London are set to open higher on Monday as interest rate expectations held steady despite Friday's bumper US nonfarm payrolls report.

Read more
9 Oct 2023 07:20

GSK inks deal to promote shingles vaccine in China

(Sharecast News) - GSK has entered into a new exclusive vaccine partnership in China that will extend the availability of its shingle vaccine Shingrix, which will see the UK-listed group generate £2.5bn over the next three years.

Read more
8 Oct 2023 11:36

Sunday newspaper round-up: Renewi, Metro Bank, New homes

(Sharecast News) - Some of Renewi's major shareholders are divided as to whether the recycling company should engage with Australian suitor Macquarie. One major shareholder has told Renewi's board that it should not until Macquarie raised its £636m bid, but another top ten shareholder told The Sunday Times that it should talk to the Australian outfit anyways. Macquarie has until 26 October to make a firm offer. - The Sunday Times

Read more
6 Oct 2023 08:17

GSK raises £885.6m from Haleon share sale

(Sharecast News) - GSK said on Friday that it has sold 270m shares in Haleon - the consumer health business it spun off last year - raising around £885.6m.

Read more
6 Oct 2023 07:57

UPDATE: GSK banks GBP886 million from Haleon share sale

(Alliance News) - GSK PLC on Friday said it received GBP885.6 million in gross proceeds from its sale of shares in consumer healthcare spin-off Haleon PLC.

Read more
6 Oct 2023 07:46

LONDON BRIEFING: Wetherspoon swings to profit; UK house prices fall

(Alliance News) - Stocks in London are called to open higher on Friday, as investors eye a key nonfarm payroll reading in the US.

Read more
5 Oct 2023 15:47

UK dividends calendar - next 7 days

Friday 6 October 
Admiral Group PLCdividend payment date
Alfa Financial Software Holdings PLCspecial dividend payment date
Anglo-Eastern Plantations PLCdividend payment date
Blackrock World Mining Trust PLCdividend payment date
Cairn Homes PLCdividend payment date
Dalata Hotel Group PLCdividend payment date
Drax Group PLCdividend payment date
Glanbia PLCdividend payment date
GlobalData PLCdividend payment date
Goodwin PLCdividend payment date
Greggs PLCdividend payment date
Intertek Group PLCdividend payment date
Irish Continental Group PLCdividend payment date
JPMorgan American Investment Trust PLCdividend payment date
JPMorgan Global Growth & Income PLCdividend payment date
Land Securities Group PLCdividend payment date
Personal Assets Trust PLCdividend payment date
Quartix Technologies PLCdividend payment date
Serco Group PLCdividend payment date
Walker Crips Group PLCdividend payment date
Warehouse REIT PLCdividend payment date
Zotefoams PLCdividend payment date
Monday 9 October 
Henderson Smaller Cos Investment Trust PLCdividend payment date
LondonMetric Property PLCdividend payment date
Tuesday 10 October 
LSL Property Services PLCdividend payment date
Wednesday 11 October 
Assura PLCdividend payment date
Rathbones Group PLCdividend payment date
Thursday 12 October 
Blackrock Latin American Investment Trust PLCex-dividend payment date
Breedon Group PLCex-dividend payment date
Diageo PLCdividend payment date
GSK PLCdividend payment date
Howden Joinery Group PLCex-dividend payment date
i3 Energy PLCex-dividend payment date
Invesco Bond Income Plus Ltdex-dividend payment date
JPMorgan Asia Growth & Income PLCex-dividend payment date
JPMorgan Mid Cap Investment Trust PLCex-dividend payment date
Kingfisher PLCex-dividend payment date
MP Evans Group PLCex-dividend payment date
Macfarlane Group PLCdividend payment date
North American Income Trust PLCex-dividend payment date
Oxford Instruments PLCdividend payment date
Persimmon PLCex-dividend payment date
Personal Group Holdings PLCex-dividend payment date
Primary Health Properties PLCex-dividend payment date
Ruffer Investment Co Ltdex-dividend payment date
Senior PLCex-dividend payment date
Spirax-Sarco Engineering PLCex-dividend payment date
Strategic Equity Capital PLCex-dividend payment date
Supermarket Income REIT PLCex-dividend payment date
Taylor Wimpey PLCex-dividend payment date
Tesco PLCex-dividend payment date
TT Electronics PLCdividend payment date
WPP PLCex-dividend payment date
XP Power Ltddividend payment date
  
Copyright 2023 Alliance News Ltd. All Rights Reserved.

Read more
3 Oct 2023 18:19

IN BRIEF: GSK's Jemperli approved in UK for endometrial cancer

GSK PLC - London-based pharmaceutical company - On Monday, announces that the UK Medicines & Health Products Regulatory Agency has authorised a new indication for Jemperli, also known as dostarlimab. The drug is used as a treatment for some types of endometrial cancer and an be used to treat patients that have a tumour abnormality called mismatch repair deficient/microsatellite instability-high when the cancer is at an advanced stage when first diagnosed or has returned after previous treatment. It is now authorised to be used together with chemotherapy to slow the progression of these cancers. GSK says it is the first medicine licensed as first line treatment for primary advanced or recurrent endometrial cancer.

Read more
3 Oct 2023 11:59

LONDON MARKET MIDDAY: HSBC and StanChart help FTSE 100 outperform

(Alliance News) - London's FTSE 100 grew in confidence as Tuesday morning progressed, going into the afternoon in the green and outperforming European peers.

Read more
25 Sep 2023 09:13

LONDON BROKER RATINGS: Jefferies raises AstraZeneca to 'buy'

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning:

Read more
25 Sep 2023 08:37

TOP NEWS: GSK's Arexvy vaccine approved for adults over 60 in Japan

(Alliance News) - GSK PLC on Monday said the Japan Ministry of Health, Labour & Welfare has approved Arexvy for adults over 60.

Read more
25 Sep 2023 07:28

GSK's RSV vaccine gets approval in Japan

(Sharecast News) - GSK announced on Monday that its vaccine, Arexvy, has received approval from Japan's Ministry of Health, Labour and Welfare (MHLW) for preventing respiratory syncytial virus (RSV) disease in adults aged 60 and over.

Read more
19 Sep 2023 09:30

GSK says new HIV PrEP medication authorised by European Commission

(Alliance News) - GSK PLC on Tuesday said the European Commission has authorised ViiV Healthcare's "superior" drug Apretude to reduce the risk of sexually acquired HIV-1 infection.

Read more
18 Sep 2023 09:40

LONDON BROKER RATINGS: Jefferies likes Energean; JPMorgan raises IDS

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning:

Read more
18 Sep 2023 07:57

LONDON BRIEFING: Phoenix Group hails "impressive" first-half

(Alliance News) - Stocks in London are called lower on Monday, as investors focus on the week's upcoming central bank decisions.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.